文献速递慢阻肺

COPD长期停用吸入糖皮质激素后气道炎症增加

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
PubMed 文献 · Eur Respir J · 2017-01-03

GLUCOLD-1研究纳入114例中重度COPD患者,随机接受6或30个月丙酸氟替卡松、30个月氟替卡松/沙美特罗或安慰剂治疗,随后5年随访中由医生常规治疗。在GL1使用ICS且GL2使用ICS时间0-50%的患者中,停用ICS后支气管CD3+、CD4+、CD8+细胞和肥大细胞及痰总细胞、巨噬细胞、中性粒细胞和淋巴细胞计数均显著增加。

要点

  • 中重度COPD患者停用ICS后气道炎症细胞显著增加。
  • ICS抗炎效应在停药后不能维持。
  • 随访期间ICS使用时间0-50%的患者炎症增加明显。

核心结论

  • 停用ICS增加中重度COPD患者气道炎症,提示ICS抗炎作用在停药后未维持。

研究设计与样本

  • GLUCOLD-1研究随机114例中重度COPD患者接受6或30个月丙酸氟替卡松500µg每日两次、30个月氟替卡松/沙美特罗500/50µg每日两次或安慰剂,随后5年前瞻性随访。

主要发现

  • 在GL1使用ICS且GL2使用ICS时间0-50%的患者(n=61/85)中,GL2支气管CD3+细胞年变化倍数2.68(95%CI 1.87-3.84)、CD4+细胞1.91(95%CI 1.33-2.75)、CD8+细胞1.71(95%CI 1.15-2.53)和肥大细胞1.91(95%CI 1.36-2.68)显著增加。
  • 同组患者痰总细胞计数年变化倍数1.90(95%CI 1.42-2.54)、巨噬细胞2.10(95%CI 1.55-2.86)、中性粒细胞1.92(95%CI 1.39-2.65)和淋巴细胞2.01(95%CI 1.46-2.78)显著增加。

临床怎么用

  • COPD患者停用ICS后应关注气道炎症可能反弹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long-term treatment with inhaled corticosteroids (ICS) might attenuate lung function decline and decrease airway inflammation in a subset of patients with chronic obstructive pulmonary disease (COPD), and discontinuing ICS treatment could result in further lung function decline. We hypothesised that airway inflammation increases after ICS withdrawal following long-term ICS treatment in COPD.In the GLUCOLD-1 study (GL1), 114 patients with moderate-severe COPD were randomised to 6-month or 30-month treatment with fluticasone propionate (500 µg twice daily), 30-month treatment with fluticasone/salmeterol (500/50 µg twice daily) or placebo. During the 5-year follow-up study (GL2), patients were followed prospectively while being treated by their physician. Bronchial biopsies and induced sputum were collected at baseline, at 30 months (end of GL1) and at 7.5 years (end of GL2) to assess inflammatory cell counts. Data were analysed using linear mixed-effects models.In patients using ICS during GL1 and using ICS 0-50% of the time during GL2 (n=61/85), there were significant increases in GL2 bronchial CD3+ (fold change per year calculated as GL2 minus GL1 2.68, 95% CI 1.87-3.84), CD4+ (1.91, 95% CI 1.33-2.75) and CD8+ cells (1.71, 95% CI 1.15-2.53), and mast cells (1.91, 95% CI 1.36-2.68). The sputum total cell counts increased significantly in GL2 (1.90, 95% CI 1.42-2.54), as did counts of macrophages (2.10, 95% CI 1.55-2.86), neutrophils (1.92, 95% CI 1.39-2.65) and lymphocytes (2.01, 95% CI 1.46-2.78).ICS discontinuation increases airway inflammation in patients with moderate-severe COPD, suggesting that the anti-inflammatory effects of ICS in COPD are not maintained after ICS discontinuation.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kunz LI, Ten Hacken NH, Lapperre TS, et al. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids. Eur Respir J. 2017. PMID: 28049170. doi:10.1183/13993003.00839-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。